Tokyo, June 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058130) titled 'A study to evaluate the safety of excessive consumption of the test food' on June 9.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Cerebro Pharma Inc.
Condition:
Condition - Healthy Japanese
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To verify the safety of excessive consumption of the test food.
Basic objectives2 - Safety
Intervention:
Interventions/Control_1 - Duration: Four weeks
Test product: Food containing Mamaki p...